The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2023

Filed:

Jan. 21, 2020
Applicant:

Celera Corporation, San Juan Capistrano, CA (US);

Inventors:

Steve Ruben, Brookeville, MD (US);

Tao He, Acton, MA (US);

Candy Lee, Bethesda, MD (US);

Karen Van Orden, Gaithersburg, MD (US);

Paul Moore, North Bethesda, MD (US);

Assignee:

Celera Corporation, San Juan Capistrano, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C07K 16/30 (2006.01); C07K 14/705 (2006.01); C07K 16/40 (2006.01); C12N 9/64 (2006.01); C12N 15/113 (2010.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C12N 9/18 (2006.01); A61K 39/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3076 (2013.01); C07K 14/4748 (2013.01); C07K 14/705 (2013.01); C07K 14/70546 (2013.01); C07K 14/70596 (2013.01); C07K 16/18 (2013.01); C07K 16/2839 (2013.01); C07K 16/2896 (2013.01); C07K 16/30 (2013.01); C07K 16/303 (2013.01); C07K 16/40 (2013.01); C12N 9/18 (2013.01); C12N 9/6424 (2013.01); C12N 15/113 (2013.01); C12N 15/1137 (2013.01); C12N 15/1138 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57488 (2013.01); G01N 33/57492 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/54 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C12N 2310/14 (2013.01); C12N 2320/30 (2013.01); C12Q 2600/158 (2013.01); C12Y 301/01 (2013.01); C12Y 304/21 (2013.01); C12Y 304/21109 (2013.01);
Abstract

Methods and compositions are provided for assessing, treating, and preventing diseases, especially cancer, using cancer-associated targets (CAT). Methods and compositions are also provided for determining or predicting the effectiveness of a treatment for these diseases or for selecting a treatment, using CAT. Methods and compositions are further provided for modulating cell function using CAT. Also provided are compositions that modulate CAT (e.g., antagonists or agonists), such as antibodies, proteins, small molecule compounds, and nucleic acid agents (e.g., RNAi and antisense agents), as well as pharmaceutical compositions thereof. Further provided are methods of screening for agents that modulate CAT, and agents identified by these screening methods.


Find Patent Forward Citations

Loading…